Key facts
- This page summarizes Jack Levine's Form 4 filing for EzFill Holdings Inc (NXXT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Jun 2023, 16:15.
Jack Levine - 02 Jun 2023 Form 4 Insider Report for EzFill Holdings Inc (NXXT)
- Reporting relationship
- Director
- Issuer ticker
- NXXT
- Reported as of
- 02 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Jun 2023, 16:15:04 UTC
- Prior SEC filing
- 29 Dec 2022
- Next SEC filing
- 27 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jack Levine
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jack Levine filed Form 4 for EzFill Holdings Inc (NXXT) on 06 Jun 2023.
Change
- Previous filing in this sequence was filed on 29 Dec 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EZFL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +58,824
- Change %
- +110%
- Price
- $0.000000
- Shares after
- 112,262
- Date
- 02 Jun 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares will fully vest in 12 months from the grant date. Should the Reporting Person leave the Issuer's board of directors prior to vesting, the Reporting Person will be awarded a grant on a pro rata basis based on the time spent as a member of the board of directors. The number of shares is based on $130,000 per the Issuer's director compensation agreement with the Reporting Person and the closing price $2.21 on June 2, 2023.
Footnote F2
The Reporting Person holds 23,252 shares of Common Stock through an entity Cameo Life Sciences Investments, LLC. The number of shares reflects a one-for-eight reverse split effective on April 27, 2023.
Footnote F3
Granted pursuant to the EzFill Holdings, Inc. 2023 Equity Incentive Plan.